Bristol Myers (BMY) is up 11.6%, or $6.29 to $60.43.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers rises, AbbVie sinks after schizophrenia trials miss targets
- Bristol-Myers Squibb’s (NYSE:BMY) Schizophrenia Drug Sees Positive Results
- Silexion Therapeutics initiated with a Buy at Maxim
- Bristol Myers price target raised to $60 from $55 at BofA
- Bristol Myers Squibb Posts Robust Q3 2024 Growth